Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 635

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 635
---
                           |      80,000 |     |     |       |     * |   |     |              |         — |     |       |   — |   |     |         |     * |   |     |                             |      80,000 |     |     |       |     * |   |     |              |         — |     |       |   — |   |     |         |     * |   |

| * | Less than 1% |

| ** | Calculated based on the total number of voting shares outstanding. Pre-Business Combination, this includes all outstanding Denali Class A Ordinary Shares and Denali Class B Ordinary Shares, as both classes generally have one vote per share and vote as a single class on all matters submitted to stockholders for approval, subject to certain exceptions, including the Domestication Proposal. Post-Business Combination, this includes all shares of New Semnur Common Stock and New Semnur Series A Preferred Stock, as both classes will have one vote per share and vote as a single class. |

| (1) | The business address of each of the following individuals is 437 Madison Avenue, 27th Floor, New York, New York 10022. |

390

| (2) | The business address of each of the following individuals is 960 San Antonio Road, Palo Alto, CA 94303. |

| (3) | Consists of 3,895,833 shares subject to options exercisable within 60 days of June 30, 2025 (assuming approval of the Option Exchange Proposal and closing of the Business Combination). |

| (4) | Consists of 3,895,833 shares subject to options exercisable within 60 days of June 30, 2025 (assuming approval of the Option Exchange Proposal and closing of the Business Combination). |

| (5) | Consists of 458,333 shares subject to options exercisable within 60 days of June 30, 2025 (assuming approval of the Option Exchange Proposal and closing of the Business Combination). |

| (6) | Jiandong (Peter) Xu is the manager and controlling member of the Sponsor. As such, each of the Sponsor and Mr. Xu may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. Mr. Xu disclaims any beneficial ownership of the ordinary shares held directly by the Sponsor, and disclaims any beneficial ownership of such shares other than to the extent of any pecuniary